Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
Gespeichert in:
| Veröffentlicht in: | Dermatologic therapy 2018-11, Vol.31 (6), p.e12742-n/a |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 6 |
| container_start_page | e12742 |
| container_title | Dermatologic therapy |
| container_volume | 31 |
| creator | Gkini, M.‐A. Bewley, A.P. |
| description | |
| doi_str_mv | 10.1111/dth.12742 |
| format | Article |
| fullrecord | <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_dth_12742</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DTH12742</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3272-9457373c787ab0cd0fc2d7d7f5d3f637fbcd99a908f6a01500f760337217f2593</originalsourceid><addsrcrecordid>eNp1kL1OwzAYRS0EoqUw8ALIK0Na_zRxzIKqFihSJZYyR05sK4b8yXZauvLkuATY-JbvDuee4QJwjdEUh5tJX04xYXNyAsY4JjxKEeanIVOeRIjwZAQunHtDCBNO8TkYUUQITjEfg8-V2qmq7WrVeNhqWBpphVSN8cZB13ddb4U3OwFNAwXsQj6C3irhlYR740vYO6_eTdPXIoe6tbBUFnautUY44-7gAnatDyUjqtAP8vbDFCEHReFN29xfgjMtKqeufv4EvD4-bJfraPPy9LxcbKKCEkYiPo8ZZbRgKRM5KiTSBZFMMh1LqhPKdF5IzgVHqU4EwjFCmiWIUkYw0yTmdAJuB29hW-es0llnTS3sIcMoO-6YhR2z7x0DezOwXZ_XSv6Rv8MFYDYAe1Opw_-mbLVdD8ovd25_IA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Gkini, M.‐A. ; Bewley, A.P.</creator><creatorcontrib>Gkini, M.‐A. ; Bewley, A.P.</creatorcontrib><identifier>ISSN: 1396-0296</identifier><identifier>EISSN: 1529-8019</identifier><identifier>DOI: 10.1111/dth.12742</identifier><identifier>PMID: 30221819</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Adalimumab - administration & dosage ; Dermatologic Agents - administration & dosage ; Dermatologic Agents - adverse effects ; Drug Substitution ; Female ; Hidradenitis Suppurativa - chemically induced ; Hidradenitis Suppurativa - diagnosis ; Hidradenitis Suppurativa - therapy ; Humans ; Psoriasis - diagnosis ; Psoriasis - drug therapy ; Psoriasis - immunology ; Risk Factors ; Smoking - adverse effects ; Treatment Outcome ; Ustekinumab - administration & dosage ; Ustekinumab - adverse effects ; Young Adult</subject><ispartof>Dermatologic therapy, 2018-11, Vol.31 (6), p.e12742-n/a</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3272-9457373c787ab0cd0fc2d7d7f5d3f637fbcd99a908f6a01500f760337217f2593</citedby><cites>FETCH-LOGICAL-c3272-9457373c787ab0cd0fc2d7d7f5d3f637fbcd99a908f6a01500f760337217f2593</cites><orcidid>0000-0003-1752-7354</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdth.12742$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdth.12742$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30221819$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gkini, M.‐A.</creatorcontrib><creatorcontrib>Bewley, A.P.</creatorcontrib><title>Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?</title><title>Dermatologic therapy</title><addtitle>Dermatol Ther</addtitle><subject>Adalimumab - administration & dosage</subject><subject>Dermatologic Agents - administration & dosage</subject><subject>Dermatologic Agents - adverse effects</subject><subject>Drug Substitution</subject><subject>Female</subject><subject>Hidradenitis Suppurativa - chemically induced</subject><subject>Hidradenitis Suppurativa - diagnosis</subject><subject>Hidradenitis Suppurativa - therapy</subject><subject>Humans</subject><subject>Psoriasis - diagnosis</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriasis - immunology</subject><subject>Risk Factors</subject><subject>Smoking - adverse effects</subject><subject>Treatment Outcome</subject><subject>Ustekinumab - administration & dosage</subject><subject>Ustekinumab - adverse effects</subject><subject>Young Adult</subject><issn>1396-0296</issn><issn>1529-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL1OwzAYRS0EoqUw8ALIK0Na_zRxzIKqFihSJZYyR05sK4b8yXZauvLkuATY-JbvDuee4QJwjdEUh5tJX04xYXNyAsY4JjxKEeanIVOeRIjwZAQunHtDCBNO8TkYUUQITjEfg8-V2qmq7WrVeNhqWBpphVSN8cZB13ddb4U3OwFNAwXsQj6C3irhlYR740vYO6_eTdPXIoe6tbBUFnautUY44-7gAnatDyUjqtAP8vbDFCEHReFN29xfgjMtKqeufv4EvD4-bJfraPPy9LxcbKKCEkYiPo8ZZbRgKRM5KiTSBZFMMh1LqhPKdF5IzgVHqU4EwjFCmiWIUkYw0yTmdAJuB29hW-es0llnTS3sIcMoO-6YhR2z7x0DezOwXZ_XSv6Rv8MFYDYAe1Opw_-mbLVdD8ovd25_IA</recordid><startdate>201811</startdate><enddate>201811</enddate><creator>Gkini, M.‐A.</creator><creator>Bewley, A.P.</creator><general>John Wiley & Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-1752-7354</orcidid></search><sort><creationdate>201811</creationdate><title>Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?</title><author>Gkini, M.‐A. ; Bewley, A.P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3272-9457373c787ab0cd0fc2d7d7f5d3f637fbcd99a908f6a01500f760337217f2593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adalimumab - administration & dosage</topic><topic>Dermatologic Agents - administration & dosage</topic><topic>Dermatologic Agents - adverse effects</topic><topic>Drug Substitution</topic><topic>Female</topic><topic>Hidradenitis Suppurativa - chemically induced</topic><topic>Hidradenitis Suppurativa - diagnosis</topic><topic>Hidradenitis Suppurativa - therapy</topic><topic>Humans</topic><topic>Psoriasis - diagnosis</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriasis - immunology</topic><topic>Risk Factors</topic><topic>Smoking - adverse effects</topic><topic>Treatment Outcome</topic><topic>Ustekinumab - administration & dosage</topic><topic>Ustekinumab - adverse effects</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gkini, M.‐A.</creatorcontrib><creatorcontrib>Bewley, A.P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Dermatologic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gkini, M.‐A.</au><au>Bewley, A.P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?</atitle><jtitle>Dermatologic therapy</jtitle><addtitle>Dermatol Ther</addtitle><date>2018-11</date><risdate>2018</risdate><volume>31</volume><issue>6</issue><spage>e12742</spage><epage>n/a</epage><pages>e12742-n/a</pages><issn>1396-0296</issn><eissn>1529-8019</eissn><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>30221819</pmid><doi>10.1111/dth.12742</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-1752-7354</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1396-0296 |
| ispartof | Dermatologic therapy, 2018-11, Vol.31 (6), p.e12742-n/a |
| issn | 1396-0296 1529-8019 |
| language | eng |
| recordid | cdi_crossref_primary_10_1111_dth_12742 |
| source | MEDLINE; Wiley Online Library All Journals |
| subjects | Adalimumab - administration & dosage Dermatologic Agents - administration & dosage Dermatologic Agents - adverse effects Drug Substitution Female Hidradenitis Suppurativa - chemically induced Hidradenitis Suppurativa - diagnosis Hidradenitis Suppurativa - therapy Humans Psoriasis - diagnosis Psoriasis - drug therapy Psoriasis - immunology Risk Factors Smoking - adverse effects Treatment Outcome Ustekinumab - administration & dosage Ustekinumab - adverse effects Young Adult |
| title | Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T23%3A14%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20hidradenitis%20suppurativa%20in%20a%20patient%20treated%20with%20ustekinumab%20for%20her%20psoriasis:%20A%20potential%20paradoxical%20reaction?&rft.jtitle=Dermatologic%20therapy&rft.au=Gkini,%20M.%E2%80%90A.&rft.date=2018-11&rft.volume=31&rft.issue=6&rft.spage=e12742&rft.epage=n/a&rft.pages=e12742-n/a&rft.issn=1396-0296&rft.eissn=1529-8019&rft_id=info:doi/10.1111/dth.12742&rft_dat=%3Cwiley_cross%3EDTH12742%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30221819&rfr_iscdi=true |